Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   AVICENNA JOURNAL OF CLINICAL MEDICINE (SCIENTIFIC JOURNAL OF HAMADAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES)   fall 2018 , Volume 25 , Number 3 (SN89) ; Page(s) 134 To 141.
 
Paper: 

Effect of Sitagliptin and Vitamin D3 on Secretion of IL-6 and TNF-α Inflammatory Factors in Patients with Type 2 Diabetes

 
 
Author(s):  Mahabadi Ashtiyani Elham, Sheikh Vida, BORZOUEI SHIVA, SALEHI IRAJ, Alahgholi Hajibehzad Mahdi*
 
* Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
 
Abstract: 
Background and Objective: Diabetes mellitus is one of the most commonly reported diseases that is associated with insulin resistance and increased blood glucose levels. The aim of this study was to determine the probable anti-inflammatory effects of sitagliptin and vitamin D3 (VitD3) on pro-inflammatory IL-6 and TNF-α in patients with type 2 diabetes mellitus (T2DM). Materials and Methods: In this case-control study, 20 blood samples of patients with T2DM and healthy controls (HCs) were collected (n=20). Peripheral blood mononuclear cells (PBMCs) were isolated using the Ficoll-Paque method and cultured with Phytohemagglutinin (PHA) in the presence or absence of sitagliptin and VitD3 for 4 days. The enzyme-linked immunosorbent assay was used to analyze the levels of IL-6 and TNF-α produced by PBMCs. Results: After PHA stimulation, the production of IL-6 was increased significantly in T2DM patients compared to HCs (P=0. 03). Compared to PHA cultures, sitagliptin and VitD3 resulted in the reduction of IL-6 production in patients (P≤ 0. 001, P≤ 0. 001), and HCs (P=0. 03, P=0. 02), respectively. Moreover, with regard to the cultures with sitagliptin or VitD3, sitagliptin with VitD3 reduced the level of IL-6 in both groups of patients (P=0. 02, P=0. 002) and HCs (P=0. 002, P=0. 03). There was a significant reduction in the level of TNF-α by sitagliptin with VitD3 in patients (P=0. 04, P=0. 002) and HCs (P=0. 04, P=0. 03), compared to cultures with sitagliptin or VitD3. Conclusion: According to the results, it can be concluded that the combined use of sitagliptin and VitD3 is more influential regarding the anti-inflammatory effects on patients. In addition, the reduction of sitagliptin dose may result in decreasing its possible side effects.
 
Keyword(s): Diabetes Mellitus Type 2,Sitagliptin,Vitamin D3
 
 
References: 
  • ندارد
  •  
 
Cite:
APA: Copy

Mahabadi Ashtiyani, E., & Sheikh, V., & BORZOUEI, S., & SALEHI, I., & Alahgholi Hajibehzad, M. (2018). Effect of Sitagliptin and Vitamin D3 on Secretion of IL-6 and TNF-α Inflammatory Factors in Patients with Type 2 Diabetes. AVICENNA JOURNAL OF CLINICAL MEDICINE (SCIENTIFIC JOURNAL OF HAMADAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES), 25(3 (SN89) ), 134-141. https://www.sid.ir/en/journal/ViewPaper.aspx?id=653571



Vancouver: Copy

Mahabadi Ashtiyani Elham, Sheikh Vida, BORZOUEI SHIVA, SALEHI IRAJ, Alahgholi Hajibehzad Mahdi. Effect of Sitagliptin and Vitamin D3 on Secretion of IL-6 and TNF-α Inflammatory Factors in Patients with Type 2 Diabetes. AVICENNA JOURNAL OF CLINICAL MEDICINE (SCIENTIFIC JOURNAL OF HAMADAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES). 2018 [cited 2021April14];25(3 (SN89) ):134-141. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=653571



IEEE: Copy

Mahabadi Ashtiyani, E., Sheikh, V., BORZOUEI, S., SALEHI, I., Alahgholi Hajibehzad, M., 2018. Effect of Sitagliptin and Vitamin D3 on Secretion of IL-6 and TNF-α Inflammatory Factors in Patients with Type 2 Diabetes. AVICENNA JOURNAL OF CLINICAL MEDICINE (SCIENTIFIC JOURNAL OF HAMADAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES), [online] 25(3 (SN89) ), pp.134-141. Available at: <https://www.sid.ir/en/journal/ViewPaper.aspx?id=653571>.



 
 
Yearly Visit 77 Persian Abstract
 
Latest on Blog
Enter SID Blog